Prenetics restates FY2024, FY2023 results in audited annual report amendment
PUBT · 2d ago
Share
Listen to the news
- Prenetics filed an amended annual report with restated FY2024 and FY2023 comparative revenue figures.
- FY2025 revenue from continuing operations rose to USD 92.39 million from USD 15.94 million in FY2024.
- FY2025 loss for the year narrowed to USD 39.98 million from USD 49.81 million a year earlier.
- IM8 generated USD 60.1 million of FY2025 revenue; CircleDNA contributed USD 12.95 million.
- Adjusted EBITDA loss was USD 18.07 million, versus USD 17.73 million in FY2024.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prenetics Global Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-060650), on September 04, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending